Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain.
Pharmacol Res. 2021 Jan;163:105339. doi: 10.1016/j.phrs.2020.105339. Epub 2020 Dec 1.
Pharmacol Res. 2021.
PMID: 33276102
Free article.
Review.